Aaro J. Jalkanen

Brain uptake of ketoprofen–lysine prodrug in rats

Mikko Gynther, Aaro J. Jalkanen, Marko Lehtonen et al. · International Journal of Pharmaceutics · 2010 · 76 citations

Neurophysiology, Medicine, Neuropharmacology +6

Binding kinetics and duration of in vivo action of novel prolyl oligopeptidase inhibitors

Jarkko I. Venäläinen, J. Arturo García‐Horsman, Markus Forsberg et al. · Biochemical Pharmacology · 2006 · 69 citations

Biochemistry, Medicine, Glycobiology +6

Comparison of in vitro cell models in predicting in vivo brain entry of drugs

Jenni J. Hakkarainen, Aaro J. Jalkanen, Tiina M. Kääriäinen et al. · International Journal of Pharmaceutics · 2010 · 58 citations

Pharmacokinetic Modeling, Preclinical Drug Evaluation, Computational Neuroscience +11

L-Type Amino Acid Transporter 1 Enables the Efficient Brain Delivery of Small-Sized Prodrug across the Blood–Brain Barrier and into Human and Mouse Brain Parenchymal Cells

Ahmed B. Montaser, Juulia Järvinen, Susanne Löffler et al. · ACS Chemical Neuroscience · 2020 · 58 citations

Beneficial Effect of Prolyl Oligopeptidase Inhibition on Spatial Memory in Young but Not in Old Scopolamine‐Treated Rats

Aaro J. Jalkanen, Katja A. Puttonen, Jarkko I. Venäläinen et al. · Basic & Clinical Pharmacology & Toxicology · 2006 · 44 citations · Full text